Mydecine applies for management cease trade order
MYDECINE APPLIES FOR MANAGEMENT CEASE TRADE ORDER VANCOUVER, British Columbia, 3 May 2024 — Mydecine Innovations Group Inc. (the “Company”) (CSE: MYCO) (FSE: 0NF0) (OTC: MYCOF) (AQSE: MYIG) announces that it has requested a temporary Management Cease Trade Order (“MCTO”) from the British Columbia Securities Commission (“BCSC”) in connection with the Company’s filing of its audited annual financial statements (the “Audited Financial Statements”) and MD&A for the financial year ended December 31, 2023. The Company is requesting the MCTO in order to secure additional time to finalize its